Vaccine Resources: 4/16/21 – J&J Vaccine
Update and HHS Key Messages
As COVID-19 vaccines continue rolling out
across the country, CMS is taking action to protect the health and safety of
our nation’s patients and providers and keeping you updated on the latest
COVID-19 resources from HHS, CDC and CMS.
With information coming from many different
sources, CMS has up-to-date resources and materials to help you share
important and relevant information on the COVID-19 vaccine with the people
that you serve. You can find these and more resources on the COVID-19 Partner Resources Page and the HHS COVID Education Campaign page. We look forward to
partnering with you to encourage our beneficiaries to get vaccinated when
they have the opportunity. For more information, visit the CMS COVID-19 Policies and Guidance page.
Information for Providers
J&J COVID-19 Vaccine: Health Alert
The CDC issued a Health Alert, about the CDC and FDA’s
recommended pause in the use of the J&J COVID-19 vaccine, in part, to
ensure that the health care provider community is aware of the potential for
adverse events and can provide proper management due to the unique treatment
required with this type of blood clot. This alert includes specific
recommendations for clinicians.
Information for Partners
|
A message from the COVID-19
Community Corps::
Tuesday night, you and nearly 2,500
fellow trusted messengers joined Dr. Fauci and me to discuss the Johnson
& Johnson (J&J) vaccine recommended pause. Thank you for being there.
Your leadership in sharing the latest information about COVID-19 vaccines
with the communities you serve and engage is essential to addressing this
pandemic. I’d like to take a moment to summarize our discussion:
- On Tuesday (4/13), the Centers for Disease
Control and Prevention (CDC) and the U.S. Food and Drug
Administration (FDA) announced they are reviewing data involving a small
number of reported cases of a rare and serious type of blood clot in
individuals after receiving the J&J vaccine. FDA and CDC, out of
an abundance of caution, recommended a pause in the use of the
J&J vaccine as they review this data.
- Based on what we know now, these blood clots are
extremely rare. At the time of the announcement, a
small number of cases (6) were reported out of the nearly seven (7)
million doses of the J&J vaccine administered so far in the
United States.
- If you received the J&J vaccine more than
three weeks ago, your risk of developing a blood clot is very
low. If you got this
vaccine within the last three weeks, your risk of developing a blood
clot is also very low. That said, you should be on the lookout for
possible symptoms of a clot, which the CDC describes, here.
- The news about the J&J vaccine pause does not
affect the two other vaccines that are widely used in the United
States – Pfizer and Moderna. More
than 100 million people in the U.S. have been vaccinated safely with
these vaccines over the past several months.
- We are still confident in the overall supply of
COVID-19 vaccines for the country. The Administration has secured enough Pfizer and
Moderna doses for 300 million Americans and there is more than enough supply to
continue the current pace of vaccinations of three (3) million
shots per day.
- For people who already have appointments for
J&J vaccines, state and federal partners are working to get
these appointments rescheduled for a Pfizer or Moderna
vaccine.
- The decision to recommend a pause in administration
of the J&J vaccine shows the rigorous steps that the FDA are taking to ensure
that the American people have clear and transparent information
about the
safety and effectiveness of these vaccines.
Americans should be confident that even when the occurrence of side
effects are extremely rare, as is the case here, the CDC and FDA
will take every necessary step to communicate those to the public.
- Yesterday (4/14), the Advisory Committee on
Immunization Practices (ACIP) held a public meeting to review in
detail the information we have so far, which you can watch here. The Committee will reconvene
as quickly as possible in the next two weeks to review any
additional scientific evidence and deliberate further. CDC and FDA
will carefully consider the Committee’s recommendations when they
are made. I appreciate ACIP convening quickly and experts providing
advice that prioritizes safety.
- Here's the bottom line: The COVID-19
vaccines have already saved lives, and we still have vaccine options that are safe
and effective, and Americans should continue to get vaccinated as
soon as possible.
- As a resource, more information about the safety
of COVID-19 vaccines can always be found here.
I invite you to watch and
share these resources with your community:
Thank you for your continued partnership
in protecting the health of our nation.
Dr. Vivek Murthy
Surgeon General of the United States
|
|
|
No comments:
Post a Comment